
Avant Genomics is a female-founded company on a mission to improve how liquid biopsy samples are prepared for analyzed to improve cancer detection and care. Its platform, Avant Source, is designed to automate the extraction of cfDNA from blood samples, improving consistency and speed. The company is based in Charlottesville, Virginia, and holds exclusive IP developed at the University of Virginia.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 05/15/26 | undisclosed |
CAV Angels Global Impact Fund Halyard Capital TitletownTech Virginia Venture Partners | undisclosed |